1. Pfister, R., Häfliger, F.: Ueber Derivate und Analoge des Phenylbutazons IV: Analoge mit schwefelhaltigen Seitenketten. Helv. chim. Acta44, 232?237 (1961)
2. Burns, J.J., Yü, T.F., Ritterbrand, A., Perel, J.M., Gutman, A.B., Brodie, B.B.: A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G 25 671. J. Pharmacol. exp. Ther.119, 418?426 (1957)
3. Kuzell, W.C., Glover, R.P., Gibbs, J.O., Blau, R.A.: Effect of sulfinpyrazone on serum uric acid in gout. Geriatrics19, 894?909 (1964)
4. Ogryzlo, M.A., Digby, J.W., Montgomery, D.B., Houpt, J.B., Mackenzie, D.H., Halmos, V.: The long-term treatment of gout with sulfinpyrazone (Anturan). Kongress Rom. Minerva med.1, 263?268 (1961)
5. Smythe, H.A., Ogryzlo, M.A., Murphy, E.A., Mustard, J.F.: The effect of sulfinpyrazone (Anturan) on platelet economy and blood coagulation in man. Canad. med. Ass. J.92, 818?821 (1965)